Michaelson Jennifer
SEC CIK 1838061 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | See Remarks | 166.8K | — | $4.82M | 64 | 2021-08-18 | 2026-09-08 |
Most active insiders at CGEM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 10% | $11.93M | — |
| 2 | Michaelson Jennifer | CSO | — | $1.62M |
| 3 | Nichols Weston | 10% | $1.39M | — |
| 4 | AHMED NADIM | Pres, CEO, Dir | — | $518.0K |
| 5 | Jones Jeffrey Alan | Chief Medical Off | — | $178.9K |
| 6 | SUMER JACQUELYN L | CLO | — | $136.7K |
| 7 | Fenton Mary Kay | CFO | — | $59.9K |
Transactions 64
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-10 09:22 | 2026-09-08 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | M - OptEx | $4.30 | +4,000 | 166.8K | +2% | +$17.2K |
| DT | 2026-09-10 09:22 | 2026-09-08 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale+OE | $21.57 | -8,000 | 158.8K | -5% | -$172.6K |
| DT | 2026-08-14 17:00 | 2026-08-13 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | M - OptEx | $4.30 | +30.0K | 192.8K | +18% | +$129.0K |
| DT | 2026-08-14 17:00 | 2026-08-13 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale+OE | $20.26 | -30.0K | 162.8K | -16% | -$607.8K |
| DT | 2026-07-07 17:00 | 2026-07-06 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | M - OptEx | $4.30 | +4,000 | 170.8K | +2% | +$17.2K |
| DT | 2026-07-07 17:00 | 2026-07-06 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale+OE | $17.82 | -8,000 | 162.8K | -5% | -$142.6K |
| DT | 2026-05-06 17:00 | 2026-05-05 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | M - OptEx | $4.30 | +4,000 | 174.8K | +2% | +$17.2K |
| DMT | 2026-05-06 17:00 | 2026-05-05 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale+OE | $14.62 | -8,000 | 166.8K | -5% | -$117.0K |
| DT | 2026-03-09 | 2026-03-05 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | M - OptEx | $4.30 | +4,000 | 178.8K | +2% | +$17.2K |
| DT | 2026-03-09 | 2026-03-05 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale+OE | $15.68 | -8,000 | 170.8K | -4% | -$125.4K |
| T | 2026-02-26 | 2026-02-25 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $14.14 | -1,780 | 174.8K | -1% | -$25.2K |
| MT | 2026-02-25 | 2026-02-23+ | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $14.31 | -5,353 | 180.2K | -3% | -$76.6K |
| DMT | 2026-02-23 | 2026-02-20 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale+OE | $14.08 | -11.7K | 182.0K | -6% | -$165.4K |
| DT | 2026-02-23 | 2026-02-20 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | M - OptEx | $4.30 | +8,000 | 190.0K | +4% | +$34.4K |
| D | 2026-02-19 | 2026-02-18 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | A - Grant | $0.00 | +57.5K | 185.7K | +45% | $0 |
| 2026-02-13 | 2026-02-12 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $12.03 | -416 | 128.2K | -0.3% | -$5,004 | |
| T | 2026-01-23 | 2026-01-22 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $12.30 | -4,000 | 128.6K | -3% | -$49.2K |
| T | 2025-12-22 | 2025-12-19 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $10.01 | -1,345 | 132.6K | -1% | -$13.5K |
| 2025-12-19 | 2025-12-18 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $9.67 | -2,898 | 134.0K | -2% | -$28.0K | |
| MT | 2025-12-16 | 2025-12-12+ | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $12.23 | -3,143 | 137.9K | -2% | -$38.4K |
| T | 2025-11-25 | 2025-11-24 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $12.30 | -4,000 | 138.0K | -3% | -$49.2K |
| 2025-02-27 | 2025-02-25 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $8.53 | -3,756 | 142.0K | -3% | -$32.0K | |
| D | 2025-02-21 | 2025-02-19 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | A - Grant | $0.00 | +50.0K | 145.8K | +52% | $0 |
| T | 2025-01-07 | 2025-01-06 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $12.51 | -4,000 | 95.8K | -4% | -$50.0K |
| 2024-12-20 | 2024-12-18 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $11.41 | -4,693 | 99.8K | -4% | -$53.5K | |
| 2024-12-16 | 2024-12-12 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $12.52 | -3,489 | 104.5K | -3% | -$43.7K | |
| T | 2024-11-07 | 2024-11-05 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $15.64 | -8,000 | 107.9K | -7% | -$125.1K |
| T | 2024-09-09 | 2024-09-05 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $18.09 | -8,000 | 115.9K | -6% | -$144.7K |
| T | 2024-07-09 | 2024-07-05 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $16.33 | -8,000 | 123.9K | -6% | -$130.6K |
| 2024-07-02 | 2024-07-01 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | A - Grant | $9.00 | +2,360 | 131.9K | +2% | +$21.2K | |
| DMT | 2024-05-08 | 2024-05-06+ | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale+OE | $28.25 | -63.6K | 129.6K | -33% | -$1.80M |
| DMT | 2024-05-08 | 2024-05-06+ | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | M - OptEx | $4.30 | +55.6K | 187.6K | +42% | +$239.1K |
| D | 2024-02-23 | 2024-02-22 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | A - Grant | $0.00 | +50.0K | 137.6K | +57% | $0 |
| 2023-12-22 | 2023-12-21 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $8.50 | -1,145 | 87.6K | -1% | -$9,732 | |
| 2023-12-20 | 2023-12-18 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $8.22 | -238 | 88.7K | -0.3% | -$1,956 | |
| 2023-12-13 | 2023-12-12 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | CSO | S - Sale | $7.81 | -1,068 | 89.0K | -1% | -$8,341 | |
| 2023-06-21 | 2023-06-20 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | S - Sale | $12.94 | -238 | 90.0K | -0.3% | -$3,080 | |
| 2023-06-14 | 2023-06-12 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | S - Sale | $13.11 | -176 | 90.3K | -0.2% | -$2,307 | |
| DMT | 2023-06-08 | 2023-06-06+ | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | M - OptEx | $4.30 | +12.0K | 90.5K | +15% | +$51.6K |
| DMT | 2023-06-08 | 2023-06-06+ | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | S - Sale+OE | $12.31 | -12.0K | 90.4K | -12% | -$147.7K |
| 2023-05-19 | 2023-05-18 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | S - Sale | $8.76 | -239 | 90.4K | -0.3% | -$2,094 | |
| 2023-05-16 | 2023-05-12 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | S - Sale | $8.78 | -193 | 90.7K | -0.2% | -$1,695 | |
| 2023-04-20 | 2023-04-18 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | S - Sale | $10.71 | -238 | 90.9K | -0.3% | -$2,549 | |
| 2023-04-14 | 2023-04-12 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | S - Sale | $10.22 | -176 | 91.1K | -0.2% | -$1,799 | |
| 2023-03-27 | 2023-03-20 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | S - Sale | $11.32 | -238 | 91.3K | -0.3% | -$2,694 | |
| D | 2023-02-21 | 2023-02-17 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | A - Grant | $0.00 | +38.5K | 91.5K | +73% | $0 |
| D | 2022-11-29 | 2022-11-25 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | See Remarks | M - OptEx | $4.30 | +4,000 | 57.0K | +8% | +$17.2K |
| D | 2022-11-29 | 2022-11-25 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | See Remarks | S - Sale+OE | $13.30 | -4,000 | 53.0K | -7% | -$53.2K |
| D | 2022-09-29 | 2022-09-27 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | See Remarks | M - OptEx | $4.30 | +4,000 | 57.0K | +8% | +$17.2K |
| D | 2022-09-29 | 2022-09-27 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | See Remarks | S - Sale+OE | $12.40 | -4,000 | 53.0K | -7% | -$49.6K |
| D | 2022-08-09 | 2022-08-08 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | S - Sale+OE | $15.01 | -1,385 | 53.0K | -3% | -$20.8K |
| D | 2022-08-09 | 2022-08-08 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | M - OptEx | $4.30 | +1,385 | 54.4K | +3% | +$5,956 |
| D | 2022-07-26 | 2022-07-25 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | M - OptEx | $4.30 | +8,000 | 61.0K | +15% | +$34.4K |
| D | 2022-07-26 | 2022-07-25 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | S - Sale+OE | $14.51 | -8,000 | 53.0K | -13% | -$116.1K |
| 2022-07-05 | 2022-06-30 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | A - Grant | $10.90 | +1,620 | 53.0K | +3% | +$17.7K | |
| D | 2022-02-15 | 2022-02-11 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | Chief Development Off | A - Grant | $0.00 | +28.5K | 51.4K | +124% | $0 |
| DM | 2021-10-20 | 2021-10-18 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | See Remarks | S - Sale+OE | $21.42 | -4,000 | 23.5K | -15% | -$85.7K |
| D | 2021-10-20 | 2021-10-18 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | See Remarks | M - OptEx | $4.30 | +4,000 | 26.9K | +17% | +$17.2K |
| DM | 2021-09-21 | 2021-09-20 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | See Remarks | S - Sale+OE | $24.51 | -4,000 | 23.7K | -14% | -$98.0K |
| D | 2021-09-21 | 2021-09-20 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | See Remarks | M - OptEx | $4.30 | +4,000 | 26.9K | +17% | +$17.2K |
| DA | 2021-08-26 | 2021-08-18 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | See Remarks | M - OptEx | $4.30 | +4,000 | 26.9K | +17% | +$17.2K |
| DMA | 2021-08-26 | 2021-08-18 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | See Remarks | S - Sale+OE | $27.66 | -4,000 | 24.0K | -14% | -$110.6K |
| DM | 2021-08-24 | 2021-08-18 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | See Remarks | S - Sale+OE | $27.66 | -4,000 | 22.9K | -15% | -$110.6K |
| D | 2021-08-24 | 2021-08-18 | CGEM | Cullinan Therapeutics, Inc. | Michaelson Jennifer | See Remarks | M - OptEx | $4.30 | +4,000 | 26.9K | +17% | +$17.2K |
Purchase Sale Sale after option exercise All abbreviations